FindTrial
Sign In

Effects of Hsp27 on EMT and VM in adenoid cystic carcinoma of salivary gland

Effects of Hsp27 on EMT and VM in adenoid cystic carcinoma of salivary gland

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100051295
Enrollment
Unknown
Registered
2021-09-18
Start date
2021-10-01
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

salivary adenoid cystic carcinoma

Interventions

Hsp27 positive group:No
Hsp27 negative group:No

Sponsors

Tianjin Stomatological Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. All the newly treated patients underwent surgical treatment; 2. SACC was confirmed by histopathological examination, and the pathological sections were re-evaluated by two independent pathologists; 3. The tumor originated from the major and minor salivary glands.

Exclusion criteria

Exclusion criteria: Preoperative radiotherapy, chemotherapy, immunotherapy and other treatment.

Design outcomes

Primary

MeasureTime frame
Life Quality;—

Countries

China

Contacts

Public ContactChen Wei

Tianjin Stomatological Hospital

2994358254@qq.com+86 18602690471

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026